The Therapeutic Implications of Tea Polyphenols Against Dopamine (DA) Neuron Degeneration in Parkinson’s Disease (PD)
出版年份 2019 全文链接
标题
The Therapeutic Implications of Tea Polyphenols Against Dopamine (DA) Neuron Degeneration in Parkinson’s Disease (PD)
作者
关键词
-
出版物
Cells
Volume 8, Issue 8, Pages 911
出版商
MDPI AG
发表日期
2019-08-19
DOI
10.3390/cells8080911
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pretreatment with Tilianin improves mitochondrial energy metabolism and oxidative stress in rats with myocardial ischemia/reperfusion injury via AMPK/SIRT1/PGC-1 alpha signaling pathway
- (2019) Li Tian et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Dopamine Oxidation Products as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson’s Disease
- (2018) Alice Biosa et al. ACS Chemical Neuroscience
- Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson’s Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism
- (2018) Camila Mouhape et al. NEUROTOXICITY RESEARCH
- Chronic Caffeine Treatment Protects Against α-Synucleinopathy by Reestablishing Autophagy Activity in the Mouse Striatum
- (2018) Yanan Luan et al. Frontiers in Neuroscience
- Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
- (2017) Lena F. Burbulla et al. SCIENCE
- The Neuroprotective Effects of Phenolic Acids: Molecular Mechanism of Action
- (2017) et al. Nutrients
- Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson’s disease
- (2016) Zhimin Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: A 13 C NMR study
- (2016) Puneet Bagga et al. NEUROCHEMISTRY INTERNATIONAL
- Neuroprotection by caffeine in the MPTP model of parkinson’s disease and its dependence on adenosine A 2A receptors
- (2016) K. Xu et al. NEUROSCIENCE
- N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data
- (2016) Daniel A. Monti et al. PLoS One
- Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson’s Disease
- (2015) Nihar Das et al. CNS & Neurological Disorders-Drug Targets
- Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease
- (2015) Jacobus Petzer et al. CURRENT MEDICINAL CHEMISTRY
- Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits
- (2015) Debashis Dutta et al. NEUROCHEMISTRY INTERNATIONAL
- Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys
- (2015) M. Chen et al. NEUROSCIENCE
- Transcription Factor Nrf2: a novel target to modulate inflammatory and neuroprotective responses in Parkinson’s disease
- (2015) Antonio Cuadrado SpringerPlus
- PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
- (2014) Juan Carlos Corona et al. NEUROCHEMICAL RESEARCH
- A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson’s disease models
- (2014) Lin Li et al. Nature Communications
- New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate
- (2014) Hae-Suk Kim et al. Redox Biology
- Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols
- (2013) Angelique Camilleri et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons
- (2013) Zhi Dong Zhou et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dmp53, basket and drICE gene knockdown and polyphenol gallic acid increase life span and locomotor activity in a Drosophila Parkinson's disease model
- (2013) Hector Flavio Ortega-Arellano et al. GENETICS AND MOLECULAR BIOLOGY
- Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease
- (2013) Kay Teo et al. Translational Neurodegeneration
- Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential
- (2012) Simone Carradori et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease
- (2011) M. C. Barone et al. Disease Models & Mechanisms
- Caffeine in Parkinson's disease: A pilot open-label, dose-escalation study
- (2011) Robert D. Altman et al. MOVEMENT DISORDERS
- Role of Secondary Mediators in Caffeine-Mediated Neuroprotection in Maneb- and Paraquat-Induced Parkinson’s Disease Phenotype in the Mouse
- (2011) Sharawan Yadav et al. NEUROCHEMICAL RESEARCH
- PGC-1α Regulates Expression of Myocardial Mitochondrial Antioxidants and Myocardial Oxidative Stress After Chronic Systolic Overload
- (2010) Zhongbing Lu et al. ANTIOXIDANTS & REDOX SIGNALING
- Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: Implications for iron-related dopaminergic neuron degeneration
- (2010) Zhi Dong Zhou et al. FREE RADICAL BIOLOGY AND MEDICINE
- Glutathione Conjugates with Dopamine-Derived Quinones to Form Reactive or Non-Reactive Glutathione-Conjugates
- (2010) Zhi Dong Zhou et al. NEUROCHEMICAL RESEARCH
- Multiple roles for nicotine in Parkinson's disease
- (2009) Maryka Quik et al. BIOCHEMICAL PHARMACOLOGY
- Glutathione—a review on its role and significance in Parkinson’s disease
- (2009) Heather L. Martin et al. FASEB JOURNAL
- Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones
- (2009) Zhi Dong Zhou et al. FREE RADICAL RESEARCH
- The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease
- (2009) Teresa G. Hastings JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- The Effects of Polyphenols on Survival and Locomotor Activity in Drosophila melanogaster Exposed to Iron and Paraquat
- (2009) M. Jimenez-Del-Rio et al. NEUROCHEMICAL RESEARCH
- Transcribe to Survive: Transcriptional Control of Antioxidant Defense Programs for Neuroprotection in Parkinson’s Disease
- (2008) Joanne Clark et al. ANTIOXIDANTS & REDOX SIGNALING
- Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
- (2008) Dong-Pyo Hong et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse
- (2008) Seema Singh et al. BRAIN RESEARCH
- Endogenous dopamine (DA) renders dopaminergic cells vulnerable to challenge of proteasome inhibitor MG132
- (2008) Zhidong Zhou et al. FREE RADICAL RESEARCH
- Dopamine auto-oxidation aggravates non-apoptotic cell death induced by over-expression of human A53T mutant alpha-synuclein in dopaminergic PC12 cells
- (2008) Zhi Dong Zhou et al. JOURNAL OF NEUROCHEMISTRY
- Roles of Glutathione (GSH) in Dopamine (DA) Oxidation Studied by Improved Tandem HPLC Plus ESI-MS
- (2008) Zhi Dong Zhou et al. NEUROCHEMICAL RESEARCH
- Smoking and tea consumption delay onset of Parkinson's disease
- (2008) Boris Kandinov et al. PARKINSONISM & RELATED DISORDERS
- Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells
- (2007) Kazuhiro Nakaso et al. NEUROSCIENCE LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now